TDS Pharm Co (XKRX:464280) Other Net Income (Loss) : ₩0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2024. Start your Free Trial

What is TDS Pharm Co Other Net Income (Loss)?

TDS Pharm Co's Other Net Income (Loss) for the three months ended in Mar. 2025 was ₩0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2025 was ₩0 Mil.

TDS Pharm Co's quarterly Other Net Income (Loss) stayed the same from Sep. 2024 (₩0 Mil) to Dec. 2024 (₩0 Mil) but then increased from Dec. 2024 (₩0 Mil) to Mar. 2025 (₩0 Mil).

TDS Pharm Co's annual Other Net Income (Loss) increased from Dec. 2022 (₩0 Mil) to Dec. 2023 (₩0 Mil) but then declined from Dec. 2023 (₩0 Mil) to Dec. 2024 (₩-0 Mil).

TDS Pharm Co Other Net Income (Loss) Historical Data

The historical data trend for TDS Pharm Co's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TDS Pharm Co Other Net Income (Loss) Chart

TDS Pharm Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Other Net Income (Loss)

TDS Pharm Co Quarterly Data
	Dec20	Dec21	Dec22	Mar23	Sep23	Dec23	Mar24	Sep24	Dec24	Mar25
Other Net Income (Loss)	Get a 7-Day Free Trial					-	-	-	-	-

TDS Pharm Co Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩0 Mil.

TDS Pharm Co Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of TDS Pharm Co's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

TDS Pharm Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TDS Pharm Co Ltd (XKRX:464280) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

N/A

Address

253 Pangyo-ro, Pangyo Inno Valley, Building C, Room 403, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13486

Website

https://www.tdspharm.com

TDS Pharm Co Ltd is engaged in the development and manufacturing of the Transdermal Drug Delivery System (TDDS), which is growing as a high-growth business sector in the field of drug delivery systems (DDS). The Transdermal Drug Delivery System (TDDS) is a drug delivery system that delivers drugs through the skin at a controlled speed. It has the advantages of increasing patient compliance with drugs, maximizing efficacy and effectiveness, such as minimizing side effects in the liver and digestive organs, controlling absorption rate, controlling discontinuation, controlling effective blood concentration, and enabling long-term continuous administration, and reducing burden compared to oral and injection drugs.

TDS Pharm Co Headlines

No Headlines